Failure of the ubiquitin–proteasome system in Parkinson's disease (original) (raw)

• Forno, L. S. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55, 259–272 (1996).
  Article CAS Google Scholar
• Goedert, M. Alpha-synuclein and neurodegenerative diseases. Nature Rev. Neurosci. 2, 492–501 (2001).
  Article CAS Google Scholar
• Schapira, A. H. et al. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 2142–2145 (1990).
  Article CAS Google Scholar
• Sian, J. et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348–355 (1994).
  Article CAS Google Scholar
• Dexter, D. T. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114, 1953–1975 (1991).
  Article Google Scholar
• McNaught, K. S., Lee, M.-H., Hyun, D.-H. & Jenner, P. in Parkinson's Disease, Advances in Neurology (eds Calne, D. B. & Calne, S. M.) 73–82 (Lippincott, Williams and Wilkins, Philadelphia, 2001).
  Google Scholar
• Halliwell, B. & Jenner, P. Impaired clearance of oxidised proteins in neurodegenerative diseases. Lancet 351, 1510 (1998).
  Article CAS Google Scholar
• Alam, Z. I. et al. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69, 1326–1329 (1997).
  Article CAS Google Scholar
• Lopiano, L. et al. Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation. Neurochem. Int. 37, 331–336 (2000).
  Article CAS Google Scholar
• McNaught, K. S. & Jenner, P. Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297, 191–194 (2001).
  Article CAS Google Scholar
• Sherman, M. Y. & Goldberg, A. L. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29, 15–32 (2001).
  Article CAS Google Scholar
• Pickart, C. M. Ubiquitin in chains. Trends Biochem. Sci. 25, 544–548 (2000).
  Article CAS Google Scholar
• DeMartino, G. N. & Slaughter, C. A. The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274, 22123–22126 (1999).
  Article CAS Google Scholar
• Pollanen, M. S., Dickson, D. W. & Bergeron, C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52, 183–191 (1993).
  Article CAS Google Scholar
• Golbe, L. I., Di Iorio, G., Bonavita, V., Miller, D. C. & Duvoisin, R. C. A large kindred with autosomal dominant Parkinson's disease. Ann. Neurol. 27, 276–282 (1990).
  Article CAS Google Scholar
• Spira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J. & Nicholson, G. A. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr α-synuclein mutation. Ann. Neurol. 49, 313–319 (2001).
  Article CAS Google Scholar
• Shashidharan, P. et al. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease. Brain Res. 877, 379–381 (2000).
  Article CAS Google Scholar
• Shimura, H. et al. Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol. 45, 668–672 (1999).
  Article CAS Google Scholar
• Shimura, H. et al. Ubiquitination of a new form of α-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293, 263–269 (2001).
  Article CAS Google Scholar
• Lowe, J., McDermott, H., Landon, M., Mayer, R. J. & Wilkinson, K. D. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J. Pathol. 161, 153–160 (1990).
  Article CAS Google Scholar
• Ii, K., Ito, H., Tanaka, K. & Hirano, A. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J. Neuropathol. Exp. Neurol. 56, 125–131 (1997).
  Article CAS Google Scholar
• Good, P. F., Hsu, A., Werner, P., Perl, D. P. & Olanow, C. W. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57, 338–342 (1998).
  Article CAS Google Scholar
• Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469–6473 (1998).
  Article CAS Google Scholar
• Giasson, B. I. et al. Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science 290, 985–989 (2000).
  Article CAS Google Scholar
• Johnston, J. A., Ward, C. L. & Kopito, R. R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 1883–98 (1998).
  Article CAS Google Scholar
• Wigley, W. C. et al. Dynamic association of proteasomal machinery with the centrosome. J. Cell Biol. 145, 481–490 (1999).
  Article CAS Google Scholar
• Kopito, R. R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524–530 (2000).
  Article CAS Google Scholar
• Davies, K. J. Degradation of oxidized proteins by the 20S proteasome. Biochimie 83, 301–310 (2001).
  Article CAS Google Scholar
• Masliah, E. et al. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265–1269 (2000).
  Article CAS Google Scholar
• Feany, M. B. & Bender, W. W. A Drosophila model of Parkinson's disease. Nature 404, 394–398 (2000).
  Article CAS Google Scholar
• Hattori, N. et al. Autosomal recessive juvenile parkinsonism: a key to understanding nigral degeneration in sporadic Parkinson's disease. Neuropathology 20, S85–90 (2000).
  Article Google Scholar
• Cummings, C. J. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 24, 879–892 (1999).
  Article CAS Google Scholar
• De Silva, H. R., Khan, N. L. & Wood, N. W. The genetics of Parkinson's disease. Curr. Opin. Genet. Dev. 10, 292–298 (2000).
  Article CAS Google Scholar
• Polymeropoulos, M. H. et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274, 1197–1199 (1996).
  Article CAS Google Scholar
• Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045–2047 (1997).
  Article CAS Google Scholar
• Kruger, R. et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genet. 18, 106–108 (1998).
  Article CAS Google Scholar
• Vaughan, J. et al. The α-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease. Ann. Neurol. 44, 270–273 (1998).
  Article CAS Google Scholar
• Solano, S. M., Miller, D. W., Augood, S. J., Young, A. B. & Penney, J. B. Jr Expression of α-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann. Neurol. 47, 201–210 (2000).
  Article CAS Google Scholar
• Kanda, S., Bishop, J. F., Eglitis, M. A., Yang, Y. & Mouradian, M. M. Enhanced vulnerability to oxidative stress by α-synuclein mutations and C-terminal truncation. Neuroscience 97, 279–284 (2000).
  Article CAS Google Scholar
• Lee, M., Hyun, D., Halliwell, B. & Jenner, P. Effect of the overexpression of wild-type or mutant α-synuclein on cell susceptibility to insult. J. Neurochem. 76, 998–1009 (2001).
  Article CAS Google Scholar
• Zhou, W., Hurlbert, M. S., Schaack, J., Prasad, K. N. & Freed, C. R. Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res. 866, 33–43 (2000).
  Article CAS Google Scholar
• Borden, K. L. Structure/function in neuroprotection and apoptosis. Ann. Neurol. 44, S65–71 (1998).
  Article CAS Google Scholar
• Conway, K. A., Harper, J. D. & Lansbury, P. T. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nature Med. 4, 1318–1320 (1998).
  Article CAS Google Scholar
• Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A. & Lansbury, P. T. Jr NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709–13715 (1996).
  Article CAS Google Scholar
• Bennett, M. C. et al. Degradation of α-synuclein by proteasome. J. Biol. Chem. 274, 33855–33858 (1999).
  Article CAS Google Scholar
• Ghee, M., Fournier, A. & Mallet, J. Rat α-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex. J. Neurochem. 75, 2221–2224 (2000).
  Article CAS Google Scholar
• Tanaka, Y. et al. Inducible expression of mutant α-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum. Mol. Genet. 10, 919–926 (2001).
  Article CAS Google Scholar
• Leroy, E. et al. The ubiquitin pathway in Parkinson's disease. Nature 395, 451–452 (1998).
  Article CAS Google Scholar
• Wintermeyer, P. et al. Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport 11, 2079–2082 (2000).
  Article CAS Google Scholar
• Saigoh, K. et al. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nature Genet. 23, 47–51 (1999).
  Article CAS Google Scholar
• Ishikawa, A. & Takahashi, H. Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism. J. Neurol. 245, 4–9 (1998).
  Article Google Scholar
• Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605–608 (1998).
  Article CAS Google Scholar
• Lucking, C. B. et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N. Engl. J. Med. 342, 1560–1567 (2000).
  Article CAS Google Scholar
• Shimura, H. et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nature Genet. 25, 302–305 (2000).
  Article CAS Google Scholar
• Imai, Y. et al. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin. Cell 105, 891–902 (2001).
  Article CAS Google Scholar
• Zhang, Y. et al. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl Acad. Sci. USA 97, 13354–13359 (2000).
  Article CAS Google Scholar
• Yoritaka, A. et al. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl Acad. Sci. USA 93, 2696–2701 (1996).
  Article CAS Google Scholar
• Jenner, P. & Olanow, C. W. Understanding cell death in Parkinson's disease. Ann. Neurol. 44, S72–84 (1998).
  Article Google Scholar
• Betarbet, R. et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nature Neurosci. 3, 1301–1306 (2000).
  Article CAS Google Scholar
• Nam, S., Smith, D. M. & Dou, Q. P. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276, 13322–13330 (2001).
  Article CAS Google Scholar
• Lee, M., Hyun, D. H., Jenner, P. & Halliwell, B. Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J. Neurochem. 78, 32–41 (2001).
  Article CAS Google Scholar
• Tatton, N. A., Maclean-Fraser, A., Tatton, W. G., Perl, D. P. & Olanow, C. W. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann. Neurol. 44, S142–148 (1998).
  Article CAS Google Scholar
• Keller, J. N., Huang, F. F. & Markesbery, W. R. Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience 98, 149–156 (2000).
  Article CAS Google Scholar
• Gaczynska, M., Osmulski, P. A. & Ward, W. F. Caretaker or undertaker? The role of the proteasome in aging. Mech. Ageing Dev. 122, 235–254 (2001).
  Article CAS Google Scholar
• Gibb, W. R. & Lees, A. J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 51, 745–752 (1988).
  Article CAS Google Scholar
• McCutchen-Maloney, S. L. et al. cDNA cloning, expression, and functional characterization of PI31, a proline-rich inhibitor of the proteasome. J. Biol. Chem. 275, 18557–18565 (2000).
  Article CAS Google Scholar